Startseite
Investieren
Aktien
Deutschland
TG
Mithra Pharmaceuticals SA (1TM) Börsenkurse

Mithra Pharmaceuticals SA (1TM)

0,00

(0,00%)

Geschlossen 19 Juli 10:00PM

Mithra Pharmaceuticals SA (1TM) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

( - )

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,216 52-Wochen-Bereich 0,216

Handelsende

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

0,00

Finanzvolumen

VWAP

Mithra reports full year 2023 financial results

Mithra reports full year 2023 financial results Mithra reports full year 2023 financial results Revenues were EUR 40.2 million, down from...

Mithra announces changes to its executive management

Mithra announces changes to its executive management Mithra announces changes to its executive management Liege, Belgium, 05 March 2024 –...

Mithra initiates monetization process, receives bridge loan from existing lenders

Mithra initiates monetization process, receives bridge loan from existing lenders Mithra initiates monetization process, receives bridge...

DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase

DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase DONESTA®...

Mithra sells shares in Mayne Pharma

Mithra sells shares in Mayne Pharma Mithra sells shares in Mayne Pharma Mithra sold all 4,221,815 shares it held in Mayne Pharma...

Mithra updates on cash position

Mithra updates on cash position Mithra updates on cash position Mithra's current cash of EUR 6.5 million is expected to cover its...

Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel

Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel Mithra and Rafa Laboratories sign...

Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients

Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients...

Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial

Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3...

Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China

Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China Mithra and Gedeon Richter...

Zeitraum †	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	0	0	0	0	0	DE
52	0.216	0.216	0.216	0	0	DE
156	2.18	2.34	0.2035	6529	0.67048648	DE
260	2.18	2.34	0.2035	6529	0.67048648	DE

1TM - Frequently Asked Questions (FAQ)

What is the current Mithra Pharmaceuticals share price?

The current share price of Mithra Pharmaceuticals is 0,00 €

What is the 1 year trading range for Mithra Pharmaceuticals share price?

Mithra Pharmaceuticals has traded in the range of 0,216 € to 0,216 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
K8DWellfield Technologies Inc	0,0098 € (63,33%)	55,03k
25XSuperQ Quantum Computing Inc	0,728 € (52,94%)	65,75k
5QQStem Inc	11,84 € (47,63%)	19,9k
25MOpendoor Technologies Inc	1,9265 € (34,91%)	1,51M
RU8Renascor Resources Limited	0,0448 € (32,15%)	161,25k
TLIKArzneiwerk AG VIDA	0,30 € (-43,40%)	14,01k
7BC0Forte Group Holdings Inc	0,0505 € (-39,16%)	2
ND3Northern Dynasty Minls	0,88 € (-37,32%)	5,55M
AB3ASarepta Therapeutics Inc	12,08 € (-36,27%)	106,16k
3SHShunfeng International Clean Energy Limited	0,0018 € (-35,71%)	60k
DRHDroneShield Limited	1,958 € (1,24%)	11,25M
ABBVolatus Aerospace Inc	0,426 € (-5,75%)	6,82M
ND3Northern Dynasty Minls	0,88 € (-37,32%)	5,55M
UH7ATennant Minerals NL	0,0035 € (-22,22%)	3,35M
PLUNPlug Power Inc	1,5296 € (7,79%)	3,29M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

1TM

Mithra Pharmaceuticals

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist